医脉通年报2024

(Incorporated in the Cayman Islands with limited liability)Stock Code: 2192 Medlive Technology Co., Ltd. ANNUAL REPORT Contents目錄 Corporate Information2Financial Summary5Chairman’s Statement6Business Overview and Outlook9Management Discussion and Analysis21Directors and Senior Management34Report of Directors43Corporate Governance Report95Independent Auditor’s Report114Consolidated Statement of Profit or Loss and Other Comprehensive Income121Consolidated Statement of Financial Position123Consolidated Statement of Changes in Equity125Consolidated Statement of Cash Flows126Notes to Financial Statements129 Corporate Information公司資料 BOARD OF DIRECTORS EXECUTIVE DIRECTORS Ms. Tian Liping(Chairwoman and Chief Executive Officer)Mr. Tian Lixin(President)Mr. Tian LijunMs. Zhou Xin NON-EXECUTIVE DIRECTORS Mr. Eiji TsuchiyaMr. Kazutaka Kanairo INDEPENDENT NON-EXECUTIVE DIRECTORS Mr. Richard YehDr. Ma JunMs. Wang Shan AUDIT COMMITTEE Ms. Wang Shan(Chairwoman)Mr. Richard YehDr. Ma Jun NOMINATION COMMITTEE Ms. Tian Liping(Chairwoman)Mr. Richard YehDr. Ma JunMs. Wang Shan REMUNERATION COMMITTEE Mr. Richard Yeh(Chairman)Dr. Ma JunMs. Wang Shan COMPANY SECRETARY 20247 15 Ms. Yang YanlingMs. Chu Cheuk Ting(resigned with effect from 15 July 2024) HONG KONG SHARE REGISTRAR 1617 Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong REGISTERED OFFICE IN THE CAYMAN ISLANDS PO Box 309Ugland HouseGrand CaymanKY1-1104Cayman Islands PO Box 309Ugland HouseGrand CaymanKY1-1104Cayman Islands AUTHORIZED REPRESENTATIVES 20247 1520247 15 Mr. Tian LijunMs. Chu Cheuk Ting(resigned with effect from 15 July 2024)Ms. Yang Yanling(appointed with effect from 15 July 2024) AUDITOR 97927 Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong COMPANY’S WEBSITE www.medlive.cn www.medlive.cn STOCK CODE 2192 2192 HEADQUARTERS IN THE PRC 54 Yimaitong MansionHuangqu East Road No. 5 Courtyard Building 4Chaoyang District, BeijingPRC Corporate Information公司資料 CAYMAN ISLANDS PRINCIPAL SHARE REGISTRARAND TRANSFER OFFICE Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands PRINCIPAL PLACE OF BUSINESS IN HONG KONG 131 31/F., Tower Two, Times Square1 Matheson StreetHong Kong PRINCIPAL BANKS Bank of Beijing Co., Ltd.The Industrial Bank Co., Ltd.China CITIC Bank Corporation LimitedDBS Bank (China) LimitedChina CITIC Bank International LimitedDBS Bank (Hong Kong) LimitedPing An Bank Co., Ltd.Bank of China (Hong Kong) LimitedChina Merchants Bank Co., Ltd.JPMorgan Chase Bank Chairman’s Statement董事長報告 Dear shareholders, 2024AI30 2024 is a crucial year for China’s healthcare industry as it stridestowards high-quality development. The in-depth integration ofdigital technology with medical services has rapidly restructuredtheindustr y ecosystem,with the AI large model bringingforthunprecedented opportunities for the medical industryreform. Adhering to the philosophy of “To empower healthcarethrough technology and to drive value with data” and driven bytechnologicalinnovation,Medlive has continuously deepenedthe core capabilities of its online professional physician platformto build a closed-loop smart healthcare ecosystem that coversphysicians, pharmaceutical companies and patients. Over thepast year, with the deepening of China’s medical system reformand driven by both policy and market forces, the industry haspropelled towards a transformation characterized by “precision,complianceand digitization”.By vir tue of its nearly threedecadesof experience accumulated in medical digitization,Medlive has consistently strengthened its leading position in theindustry, maintaining its core competitiveness amidst the wavesof transformation. 2024AIAIAINCCN3,1003.11AIAI60% Medlivehas continued to refine professional medical contentandintelligent tools to assist physicians in enhancing theirclinicaldecision-making capabilities and academic researchproficiency. In 2024, the platform has further expanded its matrixofspecialized services by integrating domestic and overseasauthoritative academic resources, to create a one-stop scenariocoveringdiagnosis,learning and research for physicians.Leveraging our self-developed AI large model for medical verticaldomain, we have conducted in-depth mining and structuring ofmassive medical data and launched innovative tools, such asAI Q&A system, AI diagnosis and treatment map and AI rationalmedication system, which can help physicians swiftly sort outthe logic of the disease and mitigate medication risks, therebysignificantly improving diagnostic efficiency and safety. We havefurther deepened our collaborations with the Chinese MedicalAssociation, NCCN and other authoritative institutions, and thetotalnumber o